{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:20:24Z","timestamp":1772119224909,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Key Research and Development Plan of Anhui Province in 2022","award":["2022e07020065"],"award-info":[{"award-number":["2022e07020065"]}]},{"name":"The Key Research and Development Plan of Anhui Province in 2022","award":["2022e07020065"],"award-info":[{"award-number":["2022e07020065"]}]},{"name":"The Key Research and Development Plan of Anhui Province in 2022","award":["2022e07020065"],"award-info":[{"award-number":["2022e07020065"]}]},{"name":"The Key Research and Development Plan of Anhui Province in 2022","award":["2022e07020065"],"award-info":[{"award-number":["2022e07020065"]}]},{"name":"The Key Research and Development Plan of Anhui Province in 2022","award":["2022e07020065"],"award-info":[{"award-number":["2022e07020065"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>This study aims to compare the performance of mono-exponential (Mono), fractional-order-calculus (FROC), and multi-compartment (MC) diffusion models in differentiating prostate lesions, including benign prostatic hyperplasia (BPH) and prostate cancer (PCa), as well as classifying PCa by clinical significance and risk levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\\A prospective study was conducted with 224 men (aged 50\u201380) undergoing 3\u00a0T MR imaging. Regions of interest (ROIs) analyses were performed on quantitative parameters from Mono, FROC, and MC models. These parameters were evaluated for their ability to distinguish BPH from PCa, clinically significant (CS) from clinically insignificant (CInS) PCa, and among PCa risk levels. Group differences were assessed using the Mann\u2013Whitney U test and Kruskal\u2013Wallis test, followed by post-hoc Dunn\u2019s test. ROC curves were plotted, and AUC was calculated. Logistic regression was used for parameter combinations, and performance was evaluated via 1000 bootstrap samples. The correlation between parameter pairs was analyzed. The image quality and PCa detection capability were also evaluated visually.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In distinguishing PCa from BPH, the F1, ADC, and D parameters from the three models achieved high AUCs of 0.92, 0.91, and 0.91, respectively. For differentiating CS-PCa from CInS-PCa, the F2 parameter and the combination of C1\u2009+\u2009F2 from the MC model showed the highest AUCs (0.75 and 0.76). In assessing PCa risk levels, F2 and C1\u2009+\u2009F2 from the MC model showed the highest AUCs (0.73 and 0.74) for low vs. intermediate-risk PCa. For intermediate vs. high-risk PCa, F1, F1F2, and \u03b2\u2009+\u2009F1F2 from MC and FROC models had the highest AUCs (0.66, 0.66, and 0.71). In addition, ADC was strongly or moderately correlated to D, \u03bc, F1, F1F2, F3, C1 and C3, and not correlated to \u03b2 and F2. ADC and C1 demonstrated high image quality and strong PCa detection capability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Advanced diffusion models, particularly the MC model, demonstrated a significant improvement over ADC in differentiating prostate lesions, especially between low and intermediate-risk PCa, between intermediate and high-risk PCa, and between clinically significant and insignificant PCa. Comparable performance was observed in distinguishing BPH from PCa among three models. Moreover, the combination of MC and FROC models further enhanced differentiation accuracy, particularly in the more challenging classifications between intermediate and high-risk PCa, where ADC alone proved inadequate. These results highlight the potential clinical value of MC model and combining MC and FROC models for more precise PCa risk stratification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1007\/s00261-024-04684-z","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:08:36Z","timestamp":1739837316000},"page":"4235-4248","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Improved differentiation of prostate cancer using advanced diffusion models: a comparative study of mono-exponential, fractional-order-calculus, and multi-compartment models"],"prefix":"10.1007","volume":"50","author":[{"given":"Yongsheng","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-Xiong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengxiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongkai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wuling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengdong","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,18]]},"reference":[{"key":"4684_CR1","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68:394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"4684_CR2","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1097\/00000478-198812000-00001","volume":"12","author":"JE McNeal","year":"1988","unstructured":"McNeal JE, Redwine EA, Freiha FS, Stamey TA: Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol 1988; 12:897\u2013906.","journal-title":"Am J Surg Pathol."},{"key":"4684_CR3","doi-asserted-by":"publisher","first-page":"479","DOI":"10.6004\/jnccn.2019.0023","volume":"17","author":"JL Mohler","year":"2019","unstructured":"Mohler JL, Antonarakis ES, Armstrong AJ, et al.: Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2019; 17:479\u2013505.","journal-title":"J Natl Compr Canc Netw."},{"key":"4684_CR4","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","volume":"389","author":"HU Ahmed","year":"2017","unstructured":"Ahmed HU, El-Shater Bosaily A, Brown LC, et al.: Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet 2017; 389:815\u2013822.","journal-title":"Lancet"},{"key":"4684_CR5","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/S1470-2045(18)30569-2","volume":"20","author":"O Rouvi\u00e8re","year":"2019","unstructured":"Rouvi\u00e8re O, Puech P, Renard-Penna R, et al.: Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study. Lancet Oncol 2019; 20:100\u2013109.","journal-title":"Lancet Oncol"},{"key":"4684_CR6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1148\/radiol.11091822","volume":"261","author":"CMA Hoeks","year":"2011","unstructured":"Hoeks CMA, Barentsz JO, Hambrock T, et al.: Prostate cancer: multiparametric MR imaging for detection, localization, and staging. Radiology 2011; 261:46\u201366.","journal-title":"Radiology"},{"key":"4684_CR7","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.eururo.2015.01.030","volume":"68","author":"HU Ahmed","year":"2015","unstructured":"Ahmed HU, Dickinson L, Charman S, et al.: Focal Ablation Targeted to the Index Lesion in Multifocal Localised Prostate Cancer: a Prospective Development Study. Eur Urol 2015; 68:927\u2013936.","journal-title":"Eur Urol"},{"key":"4684_CR8","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.juro.2015.02.080","volume":"194","author":"J Le Nobin","year":"2015","unstructured":"Le Nobin J, Rosenkrantz AB, Villers A, et al.: Image Guided Focal Therapy for Magnetic Resonance Imaging Visible Prostate Cancer: Defining a 3-Dimensional Treatment Margin Based on Magnetic Resonance Imaging Histology Co-Registration Analysis. J Urol 2015; 194:364\u2013370.","journal-title":"J Urol"},{"key":"4684_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/MOU.0000000000000471","volume":"28","author":"FF Elkhoury","year":"2018","unstructured":"Elkhoury FF, Simopoulos DN, Marks LS: MR-guided biopsy and focal therapy: new options for prostate cancer management. Curr Opin Urol 2018; 28:93\u2013101.","journal-title":"Curr Opin Urol"},{"key":"4684_CR10","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.adro.2018.09.007","volume":"4","author":"AM McDonald","year":"2019","unstructured":"McDonald AM, Dobelbower MC, Yang ES, et al.: Prostate Stereotactic Body Radiation Therapy With a Focal Simultaneous Integrated Boost: Acute Toxicity and Dosimetry Results From a Prospective Trial. Adv Radiat Oncol 2019; 4:90\u201395.","journal-title":"Adv Radiat Oncol"},{"key":"4684_CR11","doi-asserted-by":"crossref","unstructured":"Logozzi M, Angelini D, Giuliani A, et al.: Increased Plasmatic Levels of PSA-Expressing Exosomes Distinguish Prostate Cancer Patients from Benign Prostatic Hyperplasia: A Prospective Study. Cancers 2019; 11.","DOI":"10.3390\/cancers11101449"},{"key":"4684_CR12","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nrclinonc.2014.69","volume":"11","author":"LM Johnson","year":"2014","unstructured":"Johnson LM, Turkbey B, Figg WD, Choyke PL: Multiparametric MRI in prostate cancer management. Nat Rev Clin Oncol 2014; 11:346\u2013353.","journal-title":"Nat Rev Clin Oncol"},{"key":"4684_CR13","doi-asserted-by":"crossref","unstructured":"Hugosson J, Godtman RA, Wallstrom J, et al.: Results after Four Years of Screening for Prostate Cancer with PSA and MRI. New England Journal of Medicine 2024.","DOI":"10.1056\/NEJMoa2406050"},{"key":"4684_CR14","doi-asserted-by":"crossref","unstructured":"Turkbey B, Rosenkrantz AB, Haider MA, et al.: Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2. Eur Urol 2019; 76:340\u2013351.","DOI":"10.1016\/j.eururo.2019.02.033"},{"key":"4684_CR15","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1002\/jmri.27393","volume":"53","author":"CC Conlin","year":"2021","unstructured":"Conlin CC, Feng CH, Rodriguez-Soto AE, et al.: Improved characterization of diffusion in normal and cancerous prostate tissue through optimization of multicompartmental signal models. J Magn Reson Imaging 2021; 53:628\u2013639.","journal-title":"J Magn Reson Imaging"},{"key":"4684_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2021.109913","volume":"143","author":"Z Li","year":"2021","unstructured":"Li Z, Dan G, Tammana V, et al.: Predicting the aggressiveness of peripheral zone prostate cancer using a fractional order calculus diffusion model. Eur J Radiol 2021; 143:109913.","journal-title":"Eur J Radiol"},{"key":"4684_CR17","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1002\/mrm.20508","volume":"53","author":"JH Jensen","year":"2005","unstructured":"Jensen JH, Helpern JA, Ramani A, Lu H, Kaczynski K: Diffusional kurtosis imaging: the quantification of non-gaussian water diffusion by means of magnetic resonance imaging. Magn Reson Med 2005; 53:1432\u20131440.","journal-title":"Magn Reson Med"},{"key":"4684_CR18","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1002\/jmri.24985","volume":"42","author":"AB Rosenkrantz","year":"2015","unstructured":"Rosenkrantz AB, Padhani AR, Chenevert TL, et al.: Body diffusion kurtosis imaging: Basic principles, applications, and considerations for clinical practice. J Magn Reson Imaging 2015; 42:1190\u20131202.","journal-title":"J Magn Reson Imaging"},{"key":"4684_CR19","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1148\/radiology.168.2.3393671","volume":"168","author":"D Le Bihan","year":"1988","unstructured":"Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M: Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 1988; 168:497\u2013505.","journal-title":"Radiology"},{"key":"4684_CR20","doi-asserted-by":"publisher","first-page":"e624","DOI":"10.5114\/pjr.2020.101476","volume":"85","author":"AE Szubert-Franczak","year":"2020","unstructured":"Szubert-Franczak AE, Naduk-Ostrowska M, Pasicz K, Podg\u00f3rska J, Skrzy\u0144ski W, Cieszanowski A: Intravoxel incoherent motion magnetic resonance imaging: basic principles and clinical applications. Pol J Radiol 2020; 85:e624\u2013e635.","journal-title":"Pol J Radiol"},{"key":"4684_CR21","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jmr.2007.11.007","volume":"190","author":"RL Magin","year":"2008","unstructured":"Magin RL, Abdullah O, Baleanu D, Zhou XJ: Anomalous diffusion expressed through fractional order differential operators in the Bloch-Torrey equation. J Magn Reson 2008; 190:255\u2013270.","journal-title":"J Magn Reson"},{"key":"4684_CR22","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/mrm.22285","volume":"63","author":"XJ Zhou","year":"2010","unstructured":"Zhou XJ, Gao Q, Abdullah O, Magin RL: Studies of anomalous diffusion in the human brain using fractional order calculus. Magn Reson Med 2010; 63:562\u2013569.","journal-title":"Magn Reson Med"},{"key":"4684_CR23","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1002\/mrm.25039","volume":"72","author":"NS White","year":"2014","unstructured":"White NS, Dale AM: Distinct effects of nuclear volume fraction and cell diameter on high b-value diffusion MRI contrast in tumors. Magn Reson Med 2014; 72:1435\u20131443.","journal-title":"Magn Reson Med"},{"key":"4684_CR24","doi-asserted-by":"publisher","first-page":"4638","DOI":"10.1158\/0008-5472.CAN-13-3534","volume":"74","author":"NS White","year":"2014","unstructured":"White NS, McDonald C, Farid N, et al.: Diffusion-weighted imaging in cancer: physical foundations and applications of restriction spectrum imaging. Cancer Res 2014; 74:4638\u20134652.","journal-title":"Cancer Res"},{"key":"4684_CR25","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1007\/s00261-020-02903-x","volume":"46","author":"G Liu","year":"2021","unstructured":"Liu G, Lu Y, Dai Y, et al.: Comparison of mono-exponential, bi-exponential, kurtosis, and fractional-order calculus models of diffusion-weighted imaging in characterizing prostate lesions in transition zone. Abdom Radiol (NY) 2021; 46:2740\u20132750.","journal-title":"Abdom Radiol (NY)"},{"key":"4684_CR26","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1002\/jmri.27623","volume":"54","author":"CH Feng","year":"2021","unstructured":"Feng CH, Conlin CC, Batra K, et al.: Voxel-level Classification of Prostate Cancer on MRI: Improving Accuracy Using Four-Compartment Restriction Spectrum Imaging. J Magn Reson Imaging 2021; 54:975\u2013984.","journal-title":"J Magn Reson Imaging"},{"key":"4684_CR27","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.euros.2022.11.009","volume":"47","author":"AY Zhong","year":"2022","unstructured":"Zhong AY, Digma LA, Hussain T, et al.: Automated Patient-level Prostate Cancer Detection with Quantitative Diffusion Magnetic Resonance Imaging. Eur Urol Open Sci 2022; 47:20\u201328.","journal-title":"Eur Urol Open Sci"},{"key":"4684_CR28","doi-asserted-by":"crossref","unstructured":"Hambrock T, Somford DM, Huisman HJ, et al.: Relationship between Apparent Diffusion Coefficients at 3.0-T MR Imaging and Gleason Grade in Peripheral Zone Prostate Cancer. Radiology 2011.","DOI":"10.1148\/radiol.091409"},{"key":"4684_CR29","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1186\/s12885-020-06942-x","volume":"20","author":"H-J Meyer","year":"2020","unstructured":"Meyer H-J, Wienke A, Surov A: Discrimination between clinical significant and insignificant prostate cancer with apparent diffusion coefficient - a systematic review and meta analysis. BMC Cancer 2020; 20:482.","journal-title":"BMC Cancer"},{"key":"4684_CR30","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/s00261-016-0848-y","volume":"42","author":"H Shaish","year":"2017","unstructured":"Shaish H, Kang SK, Rosenkrantz AB: The utility of quantitative ADC values for differentiating high-risk from low-risk prostate cancer: a systematic review and meta-analysis. Abdom Radiol (NY) 2017; 42:260\u2013270.","journal-title":"Abdom Radiol (NY)"},{"key":"4684_CR31","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1002\/cncr.20243","volume":"100","author":"R Arora","year":"2004","unstructured":"Arora R, Koch MO, Eble JN, Ulbright TM, Li L, Cheng L: Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate. Cancer 2004; 100:2362\u20132366.","journal-title":"Cancer"},{"key":"4684_CR32","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1007\/s00330-012-2432-3","volume":"22","author":"G Th\u00f6rmer","year":"2012","unstructured":"Th\u00f6rmer G, Otto J, Reiss-Zimmermann M, et al.: Diagnostic value of ADC in patients with prostate cancer: influence of the choice of b values. Eur Radiol 2012; 22:1820\u20131828.","journal-title":"Eur Radiol"},{"key":"4684_CR33","doi-asserted-by":"crossref","unstructured":"Magin RL: Fractional calculus models of complex dynamics in biological tissues. Computers & Mathematics with Applications 2010; 59:1586\u20131593. [Fractional Differentiation and Its Applications]","DOI":"10.1016\/j.camwa.2009.08.039"},{"key":"4684_CR34","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1007\/s00330-014-3511-4","volume":"25","author":"Y-D Zhang","year":"2015","unstructured":"Zhang Y-D, Wang Q, Wu C-J, et al.: The Histogram Analysis of Diffusion-Weighted Intravoxel Incoherent Motion (IVIM) Imaging for Differentiating the Gleason grade of Prostate Cancer. Eur Radiol 2015; 25:994\u20131004.","journal-title":"Eur Radiol"},{"key":"4684_CR35","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1148\/radiol.2017162321","volume":"284","author":"T Tamada","year":"2017","unstructured":"Tamada T, Prabhu V, Li J, Babb JS, Taneja SS, Rosenkrantz AB: Prostate Cancer: Diffusion-weighted MR Imaging for Detection and Assessment of Aggressiveness-Comparison between Conventional and Kurtosis Models. Radiology 2017; 284:100\u2013108.","journal-title":"Radiology"},{"key":"4684_CR36","doi-asserted-by":"publisher","first-page":"358","DOI":"10.2214\/AJR.17.18934","volume":"211","author":"Y Si","year":"2018","unstructured":"Si Y, Liu R-B: Diagnostic Performance of Monoexponential DWI Versus Diffusion Kurtosis Imaging in Prostate Cancer: A Systematic Review and Meta-Analysis. AJR Am J Roentgenol 2018; 211:358\u2013368.","journal-title":"AJR Am J Roentgenol"},{"key":"4684_CR37","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1148\/radiol.2020192330","volume":"296","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Wu HH, Priester A, et al.: Prostate Microstructure in Prostate Cancer Using 3-T MRI with Diffusion-Relaxation Correlation Spectrum Imaging: Validation with Whole-Mount Digital Histopathology. Radiology 2020; 296:348\u2013355.","journal-title":"Radiology"},{"key":"4684_CR38","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1148\/radiol.2021204459","volume":"302","author":"A Chatterjee","year":"2022","unstructured":"Chatterjee A, Mercado C, Bourne RM, et al.: Validation of Prostate Tissue Composition by Using Hybrid Multidimensional MRI: Correlation with Histologic Findings. Radiology 2022; 302:368\u2013377.","journal-title":"Radiology"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-024-04684-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-024-04684-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-024-04684-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T05:52:22Z","timestamp":1757137942000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-024-04684-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,18]]},"references-count":38,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["4684"],"URL":"https:\/\/doi.org\/10.1007\/s00261-024-04684-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5100621\/v1","asserted-by":"object"}]},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,18]]},"assertion":[{"value":"17 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Xu Yan and Mengxiao Liu were employees of Siemens Healthineers, and work as a MR research scientist and doing technique support in this study under Siemens collaboration regulation without any payment and personal concern regarding with this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}